Skip to content
SkimSkim home
In deliveryUnited KingdomGoodsFramework agreement£616,714,000Add to pipeline

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Awarded to Accord-UK Ltd, Amgen Ltd, AstraZeneca +25 more

NHS England(buyer)

Published
Published 10 February 2025
Deadline
Closed 18 March 2025

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS England has awarded a framework agreement for branded medicines comprising two tranches: one covering London and the South of England (September 2025 to August 2027) and one for adult influenza vaccines nationally (September 2025 to August 2026). The contract was awarded on 24 June 2025 to 29 pharmaceutical suppliers including Accord-UK Ltd, Amgen Ltd, AstraZeneca, Sanofi, Bayer, Biogen, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Pfizer, Roche, and others, with a framework value of approximately £616.7 million.

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Lots (2)

  • Lot 1 - CM/PHR/24/5718/01 - Tranche A for London and South of England

    Please check this box if you have offered against Lot 1 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

    £565,223,000
  • Lot 2 - CM/PHR/24/5718/02 - National Adult Influenza

    Please check this box if you have offered against Lot 2 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

    £51,481,000

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£616,714,000
Procedure
Open
Contract type
Framework agreement
Published
10 February 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£29
Award date
24 June 2025
Contract period
31 August 2025 → 31 August 2027
Winners
  • Accord-UK Ltd
  • Amgen Ltd
  • AstraZeneca
  • Aventis Pharma ltd t/a Sanofi
  • Bayer Plc
  • Biogen
  • CST Pharma Limited
  • Chugai Pharma UK Ltd
  • Dr.Reddy's Laboratories (UK) Limited
  • Eli Lilly and Company Ltd
  • Gedeon Richter UK Ltd
  • GlaxoSmithKline UK Limited
  • Janssen-Cilag Ltd
  • Manx Healthcare Ltd
  • Merck Serono Limited
  • Mylan
  • Napp Pharmaceuticals Ltd
  • Novo Nordisk
  • Orifarm UK
  • Pfizer Ltd
  • Pharmacosmos UK Ltd
  • Roche Products Ltd
  • Sandoz Ltd
  • Seqirus UK Limited
  • Sun Pharma UK Ltd
  • Teva UK Limited
  • Thornton and Ross Ltd
  • Vifor Pharma UK Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    24 July 2025

  2. Contract Notice

    10 February 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.